New Sedative May Bring Predictable Results, Faster Recovery Times for Colonoscopy

A new sedative drug remimazolam was studied for patients undergoing colonoscopy, and may serve as a viable alternative to other available sedatives, according to an EndoNurse report.

Remimazolam is a benzodiazepine-type sedative that was developed using molecular-level techniques. A recent study showed the drug to have a faster onset, more predictable effects and shorter recovery time for patients than other drugs used during colonoscopy.

A study on the drug was published in the most recent issue of Anesthesia & Analgesia.

More Articles on Gastroenterology:
Eliminating Dietary Gluten May Decrease Chance of Developing Type 1 Diabetes
5 Key Trends in GI/Endoscopy
The Latest in GI Cancer: Q&A With Dr. Neville Bamji of New York Gastroenterology Associates

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast